# Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.

> PubMed lists PMID 21645505 in European journal of pharmacology as Journal Article, with publication-date metadata of 2011-05-30 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-21645505-bpc-157:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-21645505-bpc-157/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21645505-bpc-157-v1.json
- Content SHA-256: `eac1bf211ba34316eae512fc45c2dc301a89a3a004dc32788ccf9caad6e7115f`

## Claims and source pins

### Headline

Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. ([`pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8`](#source-pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8))

### Summary

PubMed lists PMID 21645505 in European journal of pharmacology as Journal Article, with publication-date metadata of 2011-05-30 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8`](#source-pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8))

### Paragraph 1

PubMed lists PMID 21645505 in European journal of pharmacology as Journal Article, with publication-date metadata of 2011-05-30 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8`](#source-pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8`](#source-pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8))

## Sources

<a id="source-pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8"></a>
- **Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. · retained source version 1:2018-12-01:current:8950028bf2b8c7658f6215e80c51db01816a254a110b6ab6f05a9753a4f00500** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/21645505/) (`pubmed-observation-pmid-21645505-2018-12-01-8950028bf2b8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21645505-bpc-157-v1.json SHA-256: eac1bf211ba34316eae512fc45c2dc301a89a3a004dc32788ccf9caad6e7115f.